Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





SARS-CoV-2 Found in Blood Test on Hospital Admission Can Predict Severe COVID-19

By HospiMedica International staff writers
Posted on 03 Sep 2020
Researchers have found that a blood test on hospital admission showing the presence or absence of SARS-CoV-2 can identify patients at a high risk of severe COVID-19 and admitted patients without the novel coronavirus in their blood have a good chance of rapid recovery.

Researchers at Karolinska Institutet (Stockholm, Sweden) and Danderyd Hospital (Danderyd, Sweden) who took blood samples from patients with confirmed COVID-19 infection within three days of admission found that patients with measurable levels of SARS-CoV-2 in their blood were seven times more likely to develop critical symptoms and eight times more likely to die within 28 days.

The researchers analyzed the presence of viral RNA in the blood using a standard hospital technique called PCR on samples taken from a total of 167 patients. More...
Out of them, 61 patients had measurable levels of the virus in their blood and 15/61 (25%) died within 28 days of blood sampling. This can be compared with three deaths (3%) amongst the 106 patients who did not have measurable levels of virus in their blood. The presence of virus in the blood increased with age and was much more common in patients over the age of 60 years.

“This readily available test allows us to identify patient groups at high or low risk of severe COVID-19, which enables us to better guide the treatment and monitoring of these patients”, said the study’s lead author Karl Hagman, infectious diseases consultant at Danderyd Hospital and doctoral student at Karolinska Institutet’s Department of Clinical Sciences at the same hospital.

Related Links:
Karolinska Institutet
Danderyd Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.